BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 10965096)

  • 1. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
    Traub WH
    Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesii.
    Stock I; Grueger T; Wiedemann B
    Int J Antimicrob Agents; 2003 Jul; 22(1):35-47. PubMed ID: 12842326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the antibiotic resistance rates of
    Simsek M
    Niger J Clin Pract; 2019 Jan; 22(1):125-130. PubMed ID: 30666031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
    Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibilities and bacteriological characteristics of bovine Pseudomonas aeruginosa and Serratia marcescens isolates from mastitis.
    Ohnishi M; Sawada T; Hirose K; Sato R; Hayashimoto M; Hata E; Yonezawa C; Kato H
    Vet Microbiol; 2011 Dec; 154(1-2):202-7. PubMed ID: 21783330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro susceptibility of clinical isolates of Serratia species to antimicrobial agents.
    Sofianou D; Proya E; Kondodimou A
    J Chemother; 1990 Apr; 2(2):79-81. PubMed ID: 2362189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serratia marcescens.
    Hejazi A; Falkiner FR
    J Med Microbiol; 1997 Nov; 46(11):903-12. PubMed ID: 9368530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy.
    Hemarajata P; Amick T; Yang S; Gregson A; Holzmeyer C; Bush K; Humphries RM
    J Antimicrob Chemother; 2018 May; 73(5):1256-1262. PubMed ID: 29471486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
    Yayan J; Ghebremedhin B; Rasche K
    BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An outbreak of an unusual strain of Serratia marcescens in two Dublin hospitals.
    Herra CM; Knowles SJ; Kaufmann ME; Mulvihill E; McGrath B; Keane CT
    J Hosp Infect; 1998 Jun; 39(2):135-41. PubMed ID: 9651858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of Serratia marcescens isolated from clinical materials.
    Igari J; Oguri T; Kosakai N
    Jpn J Antibiot; 1984 Sep; 37(9):1625-30. PubMed ID: 6392599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
    Ding MJ; Sung SJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An outbreak of multidrug-resistant Serratia marcescens: the importance of continuous monitoring of nosocomial infections.
    Šiširak M; Hukić M
    Acta Med Acad; 2013; 42(1):25-31. PubMed ID: 23735063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of the colistin disk test in identification of Serratia marcescens and Serratia liquefaciens.
    von Graevenitz A; Zollinger-Iten J
    Eur J Clin Microbiol; 1987 Feb; 6(1):70-1. PubMed ID: 3032610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance patterns of clinical isolates of Serratia marcescens.
    Cooksey RC; Bannister ER; Farrar WE
    Antimicrob Agents Chemother; 1975 Apr; 7(4):396-9. PubMed ID: 1096799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serratia infections: from military experiments to current practice.
    Mahlen SD
    Clin Microbiol Rev; 2011 Oct; 24(4):755-91. PubMed ID: 21976608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antibiotic susceptibility of old and current Serratia.
    Fusté E; Galisteo GJ; Jover L; Vinuesa T; Villa TG; Viñas M
    Future Microbiol; 2012 Jun; 7(6):781-6. PubMed ID: 22702530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of clinical isolates of Serratia marcescens.
    Alvarez JS; Regueiro B; Garrido MJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):523-4. PubMed ID: 391150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serratia marcescens bacteremia: clinical features and antimicrobial susceptibilities of the isolates.
    Yu WL; Lin CW; Wang DY
    J Microbiol Immunol Infect; 1998 Sep; 31(3):171-9. PubMed ID: 10496154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outbreak of Serratia marcescens Coproducing ArmA and CTX-M-15 Mediated High Levels of Resistance to Aminoglycoside and Extended-Spectrum Beta-Lactamases, Algeria.
    Batah R; Loucif L; Olaitan AO; Boutefnouchet N; Allag H; Rolain JM
    Microb Drug Resist; 2015 Aug; 21(4):470-6. PubMed ID: 25884511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.